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Nef Harbors a Major Determinant of Pathogenicity
for an AIDS-like Disease Induced by HIV-1
in Transgenic Mice
include interstitial lymphocytic pneumonitis (predomi-
nately observed in children) (McSherry, 1996), tubulo-
interstitial nephritis, and/or glomeruloslerosis (Seney et
al., 1990), wasting (Coodley et al., 1994), heart disease
(Herskowitz, 1996), and central (CNS) and peripheral
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High viral load has been associated with faster pro-Canada
2 Department of Medicine gression to and a more severe form of AIDS (Ho, 1996).
In the context of virus replication, it has been difficult3 Department of Microbiology and Immunology
UniversiteÂ de MontreÂ al to determine the effect of each of the viral gene products
on cellular functions and their contribution to the devel-Montreal, Quebec, H3C 3J7
Canada opment of AIDS. This has been best studied in animal
models, in Tg mice expressing subsets of HIV-1 genes in4 Department of Pathology
5 Department of Experimental Medicine specific tissues. These Tg mice were reported to exhibit
pathological lesions resembling some of those found inMcGill University
Montreal, Quebec, H3G 1A4 individuals with AIDS, such as nephropathy, CNS changes,
thymic atrophy, and CD41 T cell depletion, while othersCanada
6 Department of Laboratory Medicine (such as cataracts and epidermal hyperplasia) are not
usually observed in human AIDS (for review see Klotmanand Pathology
University of Toronto et al., 1995). However, none of these Tg mice developed
an immune syndrome that closely resembled humanToronto, Ontario, M5G 1L5
Canada AIDS, perhaps reflecting the lack of Tg expression in
relevant target cells.
To address this problem, we have previously con-
structed Tg mice expressing the whole coding se-
quences of HIV-1 under the regulatory sequences of theSummary
human CD4 (CD4C) gene, in the same subsets of cells
as those normally found to be infected in HIV-1-infectedTransgenic (Tg) mice expressing the complete coding
individuals, namely immature CD41CD81 thymic T cells,sequences of HIV-1 in CD41 T cells and in cells of the
mature CD41CD82 T cells, and cells of the monocyte/macrophage/dendritic lineages develop severe AIDS-
macrophage lineage (Hanna et al., 1998). These CD4C/like pathologies: failure to thrive/weight loss, diarrhea,
HIVwt Tg mice developed a very severe AIDS-like diseasewasting, premature death, thymus atrophy, loss of
with several features remarkably similar to those re-CD41 T cells, interstitial pneumonitis, and tubulo-inter-
ported in humans infected with HIV-1 (Hanna et al.,stitial nephritis. The generation of Tg mice expressing
1998). These included severe immune disease (with thy-selected HIV-1 gene(s) revealed that nef harbors a
mic atrophy, loss of peripheral T-lymphocytes, and lossmajor disease determinant. The latency and progres-
of architecture of lymphoid organs), failure to thrive and/sion (fast/slow) of the disease were strongly correlated
or weight loss, wasting, diarrhea, interstitial lymphocyticwith the levels of Tg expression. Nef-expressing Tg
pneumonitis, tubulo-interstitial nephritis, and prematurethymocytes were activated and a-CD3 hyperrespon-
death.sive with respect to tyrosine phosphorylation of sev-
To determine the contribution of individual HIV-1eral substrates, including LAT and MAPK. The similar-
genes in the pathogenesis of this AIDS-like disease ofity of this mouse model to human AIDS, particularly
CD4C/HIVwt Tg mice, we mutated selected HIV-1 genespediatric AIDS, suggests that Nef may play a critical
and constructed five mutant CD4C/HIV DNAs, whichrole in human AIDS, independently of its role in virus
were assayed in 18 lines of Tg mice. These studiesreplication.
revealed that nef harbors a major determinant of patho-
genicity.
Introduction
ResultsInfection of humans with HIV-1 induces a severe dis-
ease designated AIDS (for review see Pantaleo and
Generation of Tg Mice Harboring MutantFauci, 1995). AIDS is characterized by a gradual deple-
HIV-1 Genestion of CD41 T cells, and the disease is often associated
Five HIV-1 mutant DNAs (CD4C/HIVMutA, CD4C/HIVMutB,with other pathologies thought to be caused by HIV-1
CD4C/HIVMutC, CD4C/HIVMutG, and CD4C/HIVMutH) wereinfection rather than by opportunistic infections. These
constructed for the present study (Figure 1A). The same
regulatory elements of the human CD4 gene (CD4C)
used in our previous studies (Hanna et al., 1994, 1998)7 To whom correspondence should be addressed (e-mail: jolicop@
were used to drive the expression of these differentircm.umontreal.ca [P. J.]).
8 These authors contributed equally to this work. genes. All these transgenes were constructed on the
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Figure 1. Incidence of Death in CD4C/HIVMut
Tg Mice
(A) Structure of the CD4C/HIVMut transgenes.
The mouse CD4 enhancer (mCD4enh), the hu-
man CD4 promoter (hCD4C prom.), each of
the HIV-1NL423 mutant genomes, and the poly-
adenylation sequences from simian virus 40
(SV40) were ligated. Ex1 and 2 are the first
two untranslated exons of the hCD4 gene;
39LTR is part of the 39LTR of the HIV-1 ge-
nome. The symbol (X) means that the ORF
of the indicated HIV gene was interrupted.
Restriction sites: A, AatII; Bs, BssHII; S, SstI.
(B) Cumulative incidence of death in non-Tg
and CD4C/HIVMut Tg mice. The arrows show
the time of death of 50% (TD50) of the Tg mice
for each mutant. Each point represents the
death of a mouse. Symbols: n 5 number of
animals observed.
same DNA backbone to make comparisons between mice. At 3 weeks of age, the body weight of non-Tg and
Tg mice from different founders (MutA, F21407; MutB,them more valid. At least two to four Tg mouse lines
were established with each of these DNA constructs. F26605) was indistinguishable (non-Tg: 11.2 6 3 g [n 5
5]; Tg: 10.5 6 2.2 g [n 5 11]). However, by the end ofAll founder (F) mice were bred on the C3H background,
and progeny mice were genotyped and routinely exam- the fourth week, in more severely affected mice, the
body weight of Tg mice (8.7 6 1.7 g [n 5 11]) was muchined for signs of disease.
lower than that of non-Tg littermates (17.9 6 3.3 g [n 5
5]). In mice expressing moderate levels of the Tg, theseClinical Phenotypes of CD4C/HIVMut Mice
A fatal disease very similar to the one described in the phenotypes appeared less frequently and later in life.
None of the control non-Tg littermates (n 5 514) keptCD4C/HIVwt Tg mice (Hanna et al., 1998) developed in
mice originating from two or more founders harboring in the same cages as the Tg mice, nor those mice harbor-
ing the CD4C/HIVMutC, nor CD4C/HIVMutH Tg (n 5 145)the CD4C/HIVMutA, CD4C/HIVMutB, or CD4C/HIVMutG DNA.
The diseases induced by these three DNAs appeared developed a similar disease.
similar and exhibited a distinct latency and penetrance
according to the levels of Tg expression (see below). CD4C/HIVMutA Tg Mice
Three CD4C/HIVMutA founders (F21380, F21388, and F21407)A high proportion (z38%) of high-expresser mice had
diarrhea and edema, and most (.90%) developed weak- transmitted the Tg to their N1 progeny. Most N1 progeny
from founder F21407 became sick and died early, withinness, hypoactivity, and wasting. Wasting was the most
prevalent phenotype observed in these high-expresser the first 45 days of life (Figure 1B). A few N2 mice were
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pol, vif, vpr, tat, and vpu) were dispensable to elicit this
severe AIDS-like disease and that either rev, env, or nef
(or a combination of them) was causing this profound
phenotype.
CD4C/HIVMutB Tg Mice
To determine if env made an important contribution to
this disease, three CD4/HIVMutB founder mice (F26132,
F26605, and F26622), harboring an HIV-1 genome with
only the env gene inactivated, were produced. Tg off-
spring from two of these founders (F26605 and F26622)
developed a disease similar to that observed in CD4C/
HIVMutA mice, including early death. Again the penetrance
of disease varied and correlated well with the levels of
Tg expression (see below, Figures 2 and 3). All of the
Tg progeny from the high-expresser founder F26605
died early (,2 months) (Figure 1B), while Tg mice from
the medium-expresser F26622 line died at a later time
(Figure 1B). Interestingly, animals of the F26132 line did
not develop disease (Figure 1B), most likely as a result
of the very low levels of expression of the Tg (see below).
The capacity of the CD4C/HIVMutB DNA to elicit disease
indicated that the HIV-1 env gene was dispensable for
the appearance of this phenotype.
CD4C/HIVMutC Tg Mice
The CD4C/HIVMutC DNA harbored only two intact HIV-1
genes (rev and env). Two founders (F22564 and F22568)
were produced with this construct. No detectable phe-
notype was apparent in these founder mice or in their
offspring (n 5 81) during a period of observation of
23 months, although high levels of Tg expression were
detected in one of them (see below). The inability of this
Tg to induce a similar phenotype to that seen in CD4C/
HIVMutA and CD4C/HIVMutB mice suggested that the nef
gene, and not the rev or env gene, harbors the determi-
nant of pathogenicity.
Figure 2. Expression of HIV-1 RNA in CD4C/HIVMut Tg Mice
Northern blot analysis of HIV-1 RNA in various tissues of CD4C/
CD4C/HIVMutG Tg MiceHIVMut Tg mice.
To extend these data and confirm that indeed the nef(A) Total RNAs (10 mg) extracted from different organs of CD4C/
HIVMutA (F21407) mice were hybridized with a 32P-labeled HIV-1-spe- gene was implicated in this disease, Tg mice harboring
cific 39 end probe. only the nef gene intact were constructed. Six founders
(B and C) Comparison of the levels of RNA expression of mice from were obtained, and Tg lines could be established with
different founder Tg lines was based on the intensity of the 2 kb
four founders (F26985, F27011, F27367, and F27372) buttranscript hybridizing with a 32P-labeled HIV-1 nef-specific probe.
not from founders F26990 and F27357, whose offspringThe filters were then washed and rehybridized with the 18S ribo-
died at an early age. Offspring from all founders, exceptsomal specific probe.
Symbols: He, heart; In, Intestine; K, Kidney; Ln, lymph node; Lv, from F26985, developed a disease similar to that ob-
liver; Lu, lung; S, Spleen; T, thymus; Mgl, mammary glands of a served in CD4C/HIVMutA or CD4C/HIVMutB mice. The la-
MMTV/HIV Tg mouse used as a positive control; (2), Thymus from tency of disease varied among different lines (in the
a normal mouse.
order F26990 .. F27367 .. F27011. F27372 .
F26985) according to the levels of HIV-1 expression (see
below, Figures 2 and 3). This latency was very shortborn, but these also became moribund early in life, and
a line could not be established. However, Tg lines could (30±50 days) in mice from founders F26990 (Figure 1B)
and F27357 (data not shown) expressing the Tg at high-be established from founders F21380 and F21388 mice.
The life span of the Tg animals from these lines was est levels (see below). The absence of an obvious pheno-
type in mice from founder F26985 is likely to reflect themore variable, and the disease developed between 30
days and 16 months (Figure 1B). The latency of the low level of Tg expression in this line (see below). The
development of this severe disease in CD4C/HIVMutGdisease reflected the levels of Tg expression (see below,
Figures 2 and 3), being shorter in mice from founder mice, harboring a single known HIV-1 gene intact, the
nef gene, indicated that nef harbors a major determinantF21407 than in mice from founders F21380 or F21388.
These results indicated that several HIV-1 genes (gag, responsible for this phenotype.
Cell
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Figure 3. Expression HIV-1 Proteins in CD4C/HIVMut Tg Mice
Total protein extracts (75 mg) from thymuses and spleens of one-month-old Tg and non-Tg littermates were separated by SDS-PAGE and
analyzed by Western blotting with antibodies specific for HIV-1 Nef (A and B) or Env (C). CEM cells infected with HIV-1LAV and brain from MBP/
HIV Tg mice (Goudreau et al., 1996) were used as positive controls. (B) Semiquantitative analysis of Nef proteins. Thymic extracts were serially
diluted and compared to brain extracts from MBP/HIV Tg mice used as a standard for quantitation. (D) HIV-1 p24 proteins in CD4C/HIVMut Tg
mice. (*) These thymuses were already atrophied and partially exhausted. (E) Correlation between the time of death (TD50) of CD4C/HIVMutA,
CD4C/HIVMutB, and CD4C/HIVMutG Tg mice, as determined in Figure 1B for 11 independent Tg lines and levels of HIV-1 expression. The relative
amounts of Nef, p24 (see B and D above), and RNA (Figure 2) obtained by densitometer scanning were used to draw these curves.
CD4C/HIVMutH Tg Mice correctly regulated in all founders, being consistent with
the tissue specificity of this CD4C promoter (Hanna etTo confirm that all the HIV-1 genes other than nef had
a limited contribution in the development of these phe- al., 1994, 1998). Weaker Tg expression was detected in
kidney, lungs, intestine, and liver, most likely reflectingnotypes, we produced the CD4C/HIVMutH Tg mice, with
the complete HIV-1 coding sequences intact and only expression in T lymphocytes and/or resident macro-
phages, as previously documented (Hanna et al., 1998)the nef gene mutated. Four founders were obtained
(F37434, F37435, F37437, and F37441), and Tg lines and as reconfirmed in the present study (see below).
Expression was not detected in testis, skin, and musclewere established. Although the levels of Tg expression
in some of these lines were as high as those found in (data not shown). This pattern of expression was indis-
tinguishable from that observed previously in CD4C/other lines developing disease (Figure 2), no obvious
phenotype could be detected in these Tg mice (n 5 70) HIVwt mice (Hanna et al., 1998). As expected, the levels of
Tg RNA expression varied from founder line to another,during a 102month latency period. This result confirmed
our previous observations that nef harbored a primary most likely reflecting a positional effect at the site of Tg
insertion (Figures 2B and 2C). An excellent correlationdeterminant of pathogenicity in these Tg mice and that
the other known HIV-1 genes were dispensable for the between the levels of Tg RNA expression and the time
of death (TD50) was observed in mice from the CD4C/appearance of the phenotype.
HIVMutA, CD4C/HIVMutB, and CD4C/HIVMutG lines (Figure 3E).
Tg RNA Expression in CD4C/HIVMut Mice
Northern blot analysis showed that the three main tran- Tg HIV-1 Protein Expression in CD4C/HIVMut Mice
Western blot analysis of lymphoid organs from differentscripts of HIV-1 (8.8 kb full-length, 4.3 kb env-specific,
and the 2.0 kb multiply-spliced) were detected at higher mutant mice was performed with anti-nef and anti-env
antibodies. This analysis revealed the presence of thelevels in lymphoid than in nonlymphoid organs, in all
Tg mutant mice (Figure 2A). The Tg expression was Nef protein in lymphoid tissues of mice harboring an
AIDS-like Disease in HIV-1 Tg Mice
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Figure 4. Detection of Tg Expression in
CD4C/HIVMut Tg Mice by ISH
Tg expression was detected by ISH with HIV-
1-specific riboprobes. (A) Thymus in darkfield
of a CD4C/HIVMutG (F27367) animal hybridized
with HIV-1 antisense probe. Expression is
higher in cortex (c) than in medulla (m) (and
inset [brightfield]).
(B) An adjacent section to that shown in (A),
hybridized with HIV-1 sense probe as control.
Insets to (A) and (B); histology of medulla.
Note ISH reaction associated with cells of
lymphoid morphology (A).
(C±F) Tg expression was detected in macro-
phages from CD4C/HIVMutG mice. Plated peri-
toneal macrophages either processed for ISH
alone (C) or double labeled with a-Mac-1/ISH
(inset to C) were positive for Tg expression.
(D) Peritoneal macrophages hybridized with
sense probe and exposed to only secondary
antibody. (E) A small mononoclear cell infil-
trate in kidney was double labeled with
a-Mac-1/ISH. The majority of Mac-1 positive
cells are positive for HIV-1 RNA. (F) Negative
control for (E) (same treatment as [D]).
(G) High power of lung alveoli from a CD4C/
HIVMutB mouse (F26622) processed for ISH
and showing Tg expression in an alveolar
macrophage (arrow).
(H) The spleen from a CD4C/HIVMutG mouse
(F27367) was double labeled with a-B220/
ISH. B2201 B cells do not express high levels
of HIV-1 RNA.
(I) Negative control for (H) (same treatment
as [D]). Counterstain: hematoxylin and eosin
(H&E) (A, B, and G) or hematoxylin alone (C±F,
H, and I).
Magnifications: (A and B): 433; (C, D, and G):
2503; (E and F): 3603; (H and I): 3403; insets
to (A and B): 1503; and to (C): 4003.
intact HIV-1 nef gene (CD4/HIVMutA, CD4C/HIVMutB, and or z135 6 50 pg p24/mg of total thymus protein), the
rate at which disease developed was relatively slow.CD4C/HIVMutG) (Figure 3A), as expected. Similarly, the
expected gp160 and gp120 HIV-1 env proteins were However, above this level, disease progression was
much faster and followed a very steep curve, with adetected in lymphoid organs of CD4/HIVMutA, CD4C/
HIVMutC, and CD4C/HIVMutH Tg mice (Figure 3C). These different kinetics. Furthermore, a second threshold of
Tg expression was observed, below which no diseaseHIV-1 proteins could not be detected in target organs
of mice harboring a mutated gene. In Tg mouse lines developed within 1 year. Therefore, our data suggest
that disease progression in these Tg mice is highly de-expressing lower levels of Tg RNA, HIV-1 env and Nef
proteins could not be detected by this method. pendent on the levels of intracellular Nef proteins.
HIV-1 gag CA(p24) protein was detected by ELISA on
thymuses and spleens of mice from both CD4C/HIVMutB Tg Expression Evaluated by In Situ
Hybridization (ISH)and CD4C/HIVMutH founder lines, with higher levels ob-
served in lines expressing higher levels of Tg RNA (Fig- The organ and cell type±specific patterns of Tg expres-
sion detected in the CD4C/HIVMut Tg mice by ISH withure 3D). These results indicated that the expected HIV-1
proteins were produced in these Tg mice. 35S-labeled HIV-1-specific riboprobes (Figure 4) were
very similar to those previously described for the CD4C/
HIVwt Tg mice (Hanna et al., 1998). Briefly, thymic expres-Tg Expression Correlates with the Latency
of Disease sion of the Tg was most concentrated in the cortical
region and to a lesser extent in medullary cells (FigureThe higher Tg expression in lines exhibiting the most
acute phenotype suggested that this was an important 4A), consistent with expression in immature CD41CD81
(cortical) and in mature CD41CD82 (medullary) T cells.biological parameter. Further analysis showed a very
strong correlation between the levels of RNA, Nef, and In spleen, Tg expression was concentrated in the red
pulp and marginal zone of the white pulp (data notp24 proteins and the TD50 values (Figure 3E). The data
appear to fit a biphasic curve, indicating that below a shown). Tg expression was also observed in non-
lymphoid tissues. In the kidney, interstitial infiltratingcertain protein level (arbitrarily defined here as 14-fold
Cell
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Figure 5. Pathology and HIV-1 Transgene Expression in CD4C/HIVMut Tg Mice
(A and B) Spleens from control non-Tg (A) and CD4C/HIVMutA Tg (F21380) (B) mice. Note the extensive loss of architecture and accumulation
of fibrous tissue in (B).
(C) Histology of small intestinal mucosa from a CD4C/HIVMutA Tg mouse (F21388) showing the epithelium and lymphoid follicle.
(D) Darkfield image of the same field. The section has been processed for ISH and HIV-1-expressing cells are seen in both the lamina propria
and the lymphoid follicle.
(E) Lung from a normal non-Tg mouse.
(F) Lung from a 122month-old CD4C/HIVMutG (F27367) Tg animal showing both an interstitial pneumonitis and an extensive intra-alveolar
exudate.
(G) Kidney from a CD4C/HIVMutG animal (F26990) showing severe tubulo-interstitial disease with widespread tubular atrophy and accumulation
of proteinacous material in dilated tubules (inset).
(H) Necrotizing granuloma in the liver of a CD4C/HIVMutB (F26622) mouse. Note the surrounding normal liver tissue. Inset to (H): Wall of the
granuloma composed of mononuclear cells consistent with the morphology of lymphocytes, macrophages, and occasional polymorphonuclear
leucocytes.
(I) Darkfield image of liver granuloma from a CD4C/HIVMutB (F26622) animal processed for ISH. HIV-1-expressing cells are seen in the inflammatory
cells at the periphery of the granuloma.
(J) Histology of the same field as (I).
(K) Incidence of histopathology observed in CD4C/HIVMut Tg mice. High- (F21407, F26605, F26990) or medium- (F21380, F21388, F26622,
F27367, F27011) expresser Tg mice, as shown in Figure 3E. In parenthesis, the number of Tg mice analyzed. Some non-Tg spleens had
pathological changes that resembled the mildest pathology observed in Tg mice. Thymic atrophy was scored macroscopically. In the majority
of mice (32/36), no thymic tissue was available for histology.
Counterstain of all panels, H&E.
Magnifications: (A±D): 503; (E and F): 1403; (G and H): 483; (I and J): 2303; insets to (G): 1803 and to (H): 2303.
mononuclear cells (Figure 4E) and cells of unknown shown). Together, these results are consistent with the
specificity of the CD4C promoter, as assessed pre-identity within glomeruli (data not shown) expressed the
Tg. Infiltrating mononuclear cells expressing the Tg were viously (Hanna et al., 1994, 1998) for CD41 T cells and
for cells of the macrophage/dendritic lineage.also found in the lamina propria of the intestine (Figure
5D), in the liver (Figure 5I), and in the lung (data not
shown). Liver Kuppfer cells (data not shown), lung alveo- Pathological Assessment of CD4C/HIVMut Tg Mice
Macroscopic examination revealed severe wasting, ede-lar macrophages (Figure 4G), peritoneal macrophages
(Figure 4C), and kidney infiltrating macrophages (Figure ma, and atrophy of all lymphoid organs (thymus, spleen,
and lymph nodes) in a high proportion of the CD4C/4E) (the latter two identified with a-Mac-1 immunostain-
ing) were positive for Tg expression. However, several HIVMutA, CD4C/HIVMutB, and CD4C/HIVMutG diseased Tg
mice. These pathological changes were similar to thoseother cell types were negative for Tg expression: B cells,
as identified with a-B220 (Figure 4H), endothelial cells, observed previously in CD4C/HIVwt Tg mice (Hanna et al.,
1998). Control non-Tg littermates and CD4C/HIVMutC andsmooth muscle and connective tissue cells, myocytes of
the heart and of skeletal muscle, seminiferous tubules, CD4C/HIVMutH mice did not exhibit these abnormalities.
Histological examination also revealed changes indis-spermatocytes, and various epithelial cells, including
epithelial cells of the gastrointestinal tract, renal tubular tinguishable from those observed previously in CD4C/
HIVwt Tg mice (Hanna et al., 1998) and present at highepithelial cells, pneumocytes, and hepatocytes (data not
AIDS-like Disease in HIV-1 Tg Mice
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Table 1. Quantitation of Cells of Lymphoid Organs of Control and CD4C/HIVMutTg Mice
Number of Cells (3 106)
Mouse Linea Thymus Spleen Mes. Lymph Nodes
Non-Tg 70.9 6 23 61.9 6 20.8 20.3 6 10.6
CD4C/HIVMutA
F21407 NDb 5.2 6 4.2* 1.1 6 1.3*
F21380/21388c 32.7 6 30* 33.1 6 26.5* 9.2 6 9.3*
CD4C/HIVMutB
F26605 NDb 26.2 6 25.2* 3.5 6 5*
F26622 20.4 6 7.1* 14.4 6 13.11* 3.5 6 2.9*
F26132 77.6 6 33.4 60.1 6 14.5 7.4 6 2.4*
CD4C/HIVMutC
F22564/(22568)c 56.3 6 13.6 56.7 6 7.4 13 6 10.1
CD4C/HIVMutG
F26990 7.2* 8.1* 5.4*
F27367 24.4 6 1.6* 30.8 6 15* 5.1 6 2.4*
F27372/27011c 61.7 6 26.5 67.8 6 24 16.4 6 12.4
CD4C/HIVMutH
F37434 63.8 6 22.5 74.2 6 24.5 32.75 6 12.7
* p , 0.05 by using Student's t test. ND, not determined.
a At least five mice of each line, except for line F62990 (one mouse), were analyzed.
b The thymus of these mice was so atrophied that no cells were recovered.
c Results of two founder lines, which express similar protein levels, except CD4C/HIVMutC, were pooled.
frequency in medium- and high-expresser Tg mice (Fig- total cell number was normal at an early stage (data not
shown) and became progessively depleted later.ure 5K). Briefly, these diseased mice exhibited (1) severe
depletion of the thymocytes and peripheral lymphocytes FACS analysis was performed on thymocytes and on
cells of the peripheral lymphoid system (blood, spleen,accompanied by loss of architecture of the lymphoid
organs and fibrosis (Figure 5B); in some lymph nodes, and mesenteric lymph nodes [LN]) with antibodies
against various cell surface markers for T cells (CD4,there was a virtually complete burn out of the T cell
zone, leaving only cortical follicles (B cells) (data not CD8, TcRab, and Thy 1.2) and B cells (B220). For CD4/
HIVMutC or CD4/HIVMutH Tg mice that remained in apparentshown); (2) interstitial pneumonitis (Figure 5F); and (3)
tubulo-interstitial nephritis, with marked tubular atro- good health, the results of FACS analysis were indistin-
guishable from those of the non-Tg littermates (Tablesphy and dilatation and interstitial mononuclear infiltra-
tion (Figure 5G). This kidney pathology was more often 2 and 3). However, mice from CD4/HIVMutA, CD4/HIVMutB,
and CD4/HIVMutG lines all exibited similar abnormal pro-seen in lines in which the Tg was highly expressed (Fig-
ure 5K). files.
In the thymus, a decrease of the CD4 staining (MeanIn addition, novel pathologies were observed in some
CD4C/HIVMutA, CD4C/HIVMutB, and CD4C/HIVMutG mice in Fluorescence) of the single- (CD41CD82) and double-
(CD41CD81) positive cells could be observed at an earlywhich Tg expression was moderate and which survived
longer (.4 months). These lesions potentially resulted stage, even before a loss of cells could be documented
(Table 2 and Figure 6A). The percentage of CD41CD81from a more chronic course of disease. Thus, the lung
pathology in some animals progressed to include an and Thy1.21 populations were not significantly different
from those of non-Tg littermates, even in thymuses withoften extensive intra-alveolar exudate (Figure 5F). Livers
were found with necrotizing granulomas (Figure 5H). The significant cell loss. However, in the medium- and high-
expresser Tg mice, a decrease of the CD41CD82 andextent of these granulomas varied from a few small focal
lesions in some animals to numerous and sometimes of the TcRhigh positive T cells, which represent the mature
T cells, could be observed (Table 2, Figure 6A).extensive lesions in other animals. Finally, hyperplasia
of the lymphoid follicles of the intestinal mucosa was The same analysis performed on peripheral lymphoid
cells (spleen, blood [data not shown], mesenteric LNseen (Figure 5C). These were occasionaly associated
with an infiltration of the lamina propria with mononu- [Table 3 and Figure 6B]) also showed a progressive
decrease of the CD4 (but not of the Thy1.2) cell surfaceclear cells. Again, such pathological changes were not
observed in control non-Tg littermates nor in CD4C/ mean fluorescence, which was sometimes reflected by
the appearance of CD4Low and CD4High cells (see FigureHIVMutC or CD4C/HIVMutH Tg mice.
6B, F27011; mean fluorescence, Table 3). In addition,
at an early stage, in medium- or high-expresser mice,Analysis of Lymphoid Cells from CD4C/HIVMut
Tg Mice a depletion of Thy1.21 T cells and, more specifically, of
the CD41 T cells often accompanied by an increase ofQuantitation of cell numbers in the lymphoid organs of
diseased mice showed a severe depletion relative to CD81 T cells, could be observed. This increase of the
CD81 T cells was best seen in mesenteric LN of medium-age-matched controls, especially in Tg mice exhibiting
high levels of Tg expression (Table 1). In mice expressing expresser mice and was less often observed in the
spleen. The CD4/CD8 ratio was significantly decreasedmoderate levels of CD4C/HIVMutA, CD4C/HIVMutB, and
CD4C/HIVMutG Tg, and which became diseased later, the in these mice (Table 3). At a later stage, particularly in
Cell
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Table 2. Thymic Cell Surface Marker Analysis in CD4C/HIVMut Tg Mice
Cell populations (%) Mean Fluorescence (%)
Mouse Linea Thy 1.2 CD41CD81 CD41CD82 CD42CD81 Thy 1.2 CD4
Non-Tg 91.4 6 8.4 83.2 6 7.4 9.6 6 3.3 4.7 6 1.7 100 100
CD4C/HIVMutA
F21380/21388 91.1 6 7.2 79.6 6 8.6 5.5 6 1.3* 6 6 3.9 101.6 6 9.2 39.8 6 24*
CD4C/HIVMutB
F26622 95.3 6 2.3 83.8 6 7.3 3.7 6 1.1* 6.85 6 2.2* 104.9 6 31.5 31.5 6 12*
F26132 93.6 6 5.1 84.2 6 5.7 11.3 6 3 5.5 6 2.4 108.9 6 19 104.6 6 8.8
CD4C/HIVMutC
F22564/22568 92.2 6 4.8 81.6 6 10.4 9.3 6 3.2 4.7 6 1.2 99.5 6 21.4 97.9 6 13
CD4C/HIVMutG
F27367 93.5 6 2.1 82.3 6 1.9 8.9 6 0.3 9.1 6 1.1* 94.6 6 3.5 22.3 6 0.6*
F27372/27011 96.2 6 1.4 87.6 6 4.7 4.8 6 2.2* 5.4 6 1.4 90.9 6 11.7 35.7 6 1.8*
CD4C/HIVMutH
F37434 95.8 6 1.3 82.7 6 9.3 11.2 6 2.1 4.7 6 1.2 91.7 6 6.4 94.8 6 11.4
F37435 97.1 6 0.5 81.9 6 0.4 11.7 6 0.6 5.76 6 0.8 107.2 6 5.7 97.3 6 0.6
* p , 0.05 by using Student's t test.
a At least five mice per line, except for line F37435 (four mice), were analyzed.
medium- or high-expresser mice, the numbers of both monocytes, eosinophils, and basophils was not signifi-
cantly different in non-Tg and Tg mice from all linesCD41 and CD81 T cells were dramatically reduced. The
proportion of B2201 B cells in the peripheral organs (data not shown). However, the percentage of lympho-
cytes was lower, as expected, in diseased Tg mice fromwas found to be increased in these three mutant mice
relative to their control non-Tg littermates, possibly re- CD4C/HIVMutA, CD4C/HIVMutB, and CD4C/HIVMutG high-
and medium-expresser lines (25.3 6 10.6%, n 5 15)flecting the T cell depletion in these organs.
The lymphoproliferative capacity of the lymphoid cells than in low-expresser or control non-Tg mice (56.3 6
12.0%, n 5 17). Also, the percentage of neutrophilsof CD4C/HIVMutG (F27367) Tg mice was also assessed
before they showed signs of clinical disease. Anti-CD3 was increased in moderate- and high-expresser Tg mice
from the same lines (61.6 6 10%, n 5 15) as comparedstimulated total spleen and mesenteric LN cells from
these mice showed a decrease 3H-thymidine incorpora- to low-expresser or non-Tg mice (37.3 6 10.2%, n 5 17).
As reported before for the CD4C/HIVwt Tg mice, thetion at only 25.6 6 15.4% (n 5 4) and 35.8 6 25.1%
(n 5 4), respectively (corrected for T cell loss), of the total serum immunoglobulin (Ig) levels (mg/ml) were also
much lower (3.86 6 4, n 5 11) in diseased CD4C/HIVMutA,control non-Tg littermates, indicating functional defects
of T cells in these mice. The same spleen and LN cells CD4C/HIVMutB, and CD4C/HIVMutG high-expresser Tg mice
than in non-Tg mice (29 6 8, n 5 15). In mice expressingstimulated with LPS proliferated at 110 6 33% (n 5 4)
and 170 6 132% (n 5 4) of the control, respectively. the same Tg at medium or low levels, the levels of total
Ig were more variable, being either reduced (7.4 6 4.8)
in 25% (9/36) of Tg mice, elevated (70 6 14) in 17%Hematological Parameters of CD4C/HIVMut Tg Mice
The hemoglobin, hematocrit, number of red and white (6/36) of Tg mice, or unchanged (28.1 6 10) in 58% (21/
36) of Tg mice as compared to non-Tg controls. Thisblood cells, and platelets, as well as the percentage of
Table 3. Mesenteric Lymph Node Cell Surface Marker Analysis in CD4C/HIVMut Tg Mice
Cell populations (%) Mean Fluorescence (%)
CD4/CD8
Mouse line (a) Thy 1.2 CD41 CD81 B220 Ratio Thy 1.2 CD4
Non-Tg 63.1 6 12.4 52.5 6 7.8 18.8 6 4.8 21.4 6 7.1 2.94 6 0.7 100 100
CD4C/HIVMutA
F21407 31.1 6 0* 24 6 15.2* 18.7 6 8.4 31.1 6 18.2* 1.46 6 0.8* 112.7 6 14.8 45.2 6 23*
F21386/21388 42.3 6 7.8* 18.5 6 6.9* 24.6 6 7.2* 40.2 6 9.2* 0.81 6 0.38* 111.2 6 8.4 24.4 6 8.8*
CD4C/HIVMutB
F26605 9.1 6 6.6* 3.47 6 3.8* 5.12 6 2.6* 60.8 6 22* 0.71 6 0.8* 101.9 6 9.5 48 6 16.7*
F26622 44.8 6 6.6* 17.74 6 3* 31.5 6 13.9* 28.9 6 9.2 0.63 6 0.3* 89.3 6 9.2 22.1 6 8.4*
F26132 57.2 6 10.4 42.4 6 6.2* 23 6 7.9 30.4 6 11.3* 2.13 6 1 108.1 6 5.9 43.8 6 5.9*
CD4C/HIVMutC
F22564/22568 66.6 6 6.7 53.7 6 10.6 19.67 6 4.2 17.6 6 4.8 2.9 6 1 111 6 22.1 99.5 6 20.2
CD4C/HIVMutG
F26990 24* 14.63* 8.4* 68* 1.74* 89.5 76.8*
F27367 53.5 6 8* 20.1 6 6.7* 30.6 6 4.1* 34.1 6 7.8* 0.69 6 0.32* 89.4 6 1.20 13.6 6 8.7*
F27372/27011 50 6 4.8* 29.5 6 4.5* 27.1 6 5.8* 37.3 6 5.3* 1.15 6 0.37* 113.2 6 18.7 35.2 6 11.9*
CD4C/HIVMutH
F37434 63.4 6 3.2 53.4 6 6 16.9 6 2 25.4 6 6.5 3.2 6 0.6 96.9 6 11.8 96.4 6 15.5
F37435 69 6 6.5 50.8 6 6.1 25.1 6 2.3 21.1 6 7.8 2.03 6 0.03 108.9 6 16.6 104.1 6 25.2
* p , 0.05 by using Student's t test.
a At least five mice per line, except for lines F37435 (four mice) and F26990 (one mouse), were analyzed.
AIDS-like Disease in HIV-1 Tg Mice
171
Figure 7. Detection of Tyrosine Phosphorylated Proteins in Thymo-
cytes of CD4C/HIVMutG Tg Mice
Lysates from thymocytes of non-Tg or CD4C/HIVMutG Tg mice were
prepared after stimulation with a-CD3 for the indicated times.
(A) Lysates (5 3 105 cells) were probed by protein immunoblotting
first with anti-phosphotyrosine antibodies (4G10) (a-pY). The aster-
isk indicates two exposures times of the film. The membrane was
then washed and reprobed with anti-actin as a control for protein
loading.
(B) Lysates from thymocytes (5 3 106 cells) were immunoprecipi-
tated with antibodies for LAT. Immune complexes were resolved onFigure 6. Flow Cytofluorometric Analysis of T Cell Subsets from
SDS-PAGE and blotted with a-pY antibodies. The arrow shows LAT.CD4C/HIVMutG Tg Mice
(C) Lysates (5 3 105 cells) were probed first with anti-phospho p44/
Thymus (A) and mesenteric LN (B) cells from a non-Tg mouse and p42 MAP Kinase antibodies and then washed and reprobed with
from three representative mice each from a different founder CD4C/ anti-MAP Kinase antibodies. The arrows show p42 and p44 MAPK.
HIVMutG Tg line were analyzed by flow cytometry for the expression
of CD4, CD8, Thy1.2, and TcRab. The percentage of cells found in
each quadrant are indicated. 104 cells were analyzed.
upon a-CD3 stimulation, levels of tyrosine phosphoryla-
tion of several substrates were higher in Tg than in con-
trol non-Tg mice (Figure 7A). The pattern of the tyrosine
variation did not seem to correlate with the clinical dis- phosphorylated proteins was virtually identical in Tg and
ease phenotype. As expected, mice from CD4C/HIVMutC non-Tg thymocytes, except for the quantitative differ-
and CD4C/HIVMutH founders had Ig levels (31 6 10, n 5 ences. Identical results were obtained with thymocytes
13) not significantly different from those of control non- from CD4C/HIVMutA Tg mice (data not shown). Some pro-
Tg mice (29 6 8, n 5 15). teins most hyperphosphorylated in Tg mice had an ap-
parent mobility of 135, 120, 100, 70, 60, 45, and 36/
38 kDa and the latter species was especially evident.Increased Constitutive and a-CD3 Stimulated
Tyrosine Phosphorylation in Thymocytes Several of the proteins whose tyrosine phosphorylation
is enhanced following TcR engagement have been iden-of CD4C/HIVMutG Tg Mice
To explore the mechanism of thymic perturbation and tified (Weiss and Littman, 1994). One of them, LAT (36/
38 kDa), is of special interest since it links the TcR toT cell loss in these Tg mice, we investigated the state
of tyrosine phosphorylation after engagement of the T cellular activation (Zhang et al., 1998). Our analysis
showed that LAT was hyperphosphorylated in CD4C/cell receptor (TcR) with a-CD3. Thymocytes from CD4C/
HIVMutG Tg mice showed a constitutive increase of tyro- HIVMutG Tg mice after a-CD3 stimulation (Figure 7B). In
addition, the phosphorylation state of p44/p42 MAP Ki-sine phosphorylation of several substrates as compared
to thymocytes from non-Tg mice (Figure 7A). In addition, nase (Erk-1/Erk-2) was also found to be increased in
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thymocytes of CD4/HIVMutG (Figure 7C) and CD4C/HIVMutA respect to the tyrosine phosphorylation of several sub-
strates of TcR signaling, including some involved in early(data not shown) Tg mice, as compared to non-Tg lit-
termates. This enhanced tyrosine phosphorylation state (LAT) and late (MAP Kinase) events. Interestingly, LAT
is a substrate for the ZAP-70 tyrosine kinase and bindswas observed both constitutively and after a-CD3 stimu-
lation. Together, these results show that thymocytes to several signaling molecules and, as such, serves as a
linker to couple the TcR to downstream signaling eventsfrom CD4C/HIVMutG Tg mice are in a state of activation
and of a-CD3 hyperresponsiveness. (Zhang et al., 1998). Nef has been found to bind to MAP
kinase and to inhibit its kinase activity (Greenway et al.,
1996). The enhanced tyrosine phosphorylation of the
Discussion MAP Kinase seen in the CD4C/HIVMut Tg mice would
rather suggest that its enzyme activity is increased.
HIV-1 Nef Harbors a Major Determinant Other previous studies on the effects of HIV-1 Nef in T
of Pathogenicity in Tg Mice cells in vitro has led to contradictory results either
Our mutational analysis revealed that an AIDS-like phe- blocking or stimulating TcR signaling (Harris, 1996). In
notype could be induced in Tg mice by the expression vivo, later events in TcR signaling (calcium mobilization
of a single HIV-1 gene, nef, in CD41 T cells and in cells and proliferation) were found to be stimulated (Skowron-
of the monocyte/macrophage lineage. The other known ski et al., 1993). An enhanced constitutive and stimulated
HIV-1 genes were dispensable for the emergence of this tyrosine phosphorylation similar to the one seen in CD4/
phenotype. This result was rather surprising in view of HIVMutG Tg mice has not been reported in cells expressing
the fact that profound effects on host cell functions have wild-type HIV-1 Nef. If such a state of constitutive activa-
previously been reported to be induced in vitro by other tion were present in HIV-1-infected human T cells, it
HIV-1 proteins, more specifically by Vpr (Rogel et al., may facilitate HIV-1 replication. This activation state may
1995; Levy et al., 1993), Vpu (Willey et al., 1992), Tat also be involved in thymic atrophy and T cell loss in the
(Viscidi et al., 1989; Li et al., 1995), and the envelope CD4C/HIVMut Tg mice, since it mimics TcR induction,
gp120 and gp41 glycoproteins (Siliciano, 1996). How- which is known to induce cell death (Kroemer, 1995).
ever, the vpr, vpu, tat, and env genes were dispensable Therefore, our study may provide a molecular mecha-
for the development of the disease in CD4C/HIVMut Tg nism for the T cell loss in these Tg mice and shows that
mice. Since some of these genes have previously been this animal model can be instrumental in studying the
reported to induce impressive phenotypes, not only in effects of Nef on TcR signaling in relevant primary target
vitro but also in vivo in Tg mice (for review see Klotman cells and in unraveling unique molecular defects in-
et al., 1995), this suggests that the cell type in which duced by HIV-1.
some HIV-1 proteins are expressed is a major factor in
determining their effect. The apparent inability of env
gp120 to affect disease development may be related Does the Critical Role of nef in CD4/HIV Tg Mice
Reflect its Role in the Human Disease?to the absence of its proper receptor (the human CD4
protein) or its coreceptors in these mice. The role of nef in HIV-1 infection has emerged from in
vitro and clinical studies as well as from studies with theIn other related studies, HIV-1 nef was expressed in
T cells of Tg mice using the promoter/enhancer elements related primate lentivirus, the simian immunodeficiency
virus (SIV). Nef has been shown to affect T cell signalof the CD3d (Skowronski et al., 1993), CD2 (Brady et al.,
1993), or TcR b chain (Lindemann et al., 1994) gene. In transduction (Iafrate et al., 1997) and to downregulate
human CD4 (Garcia and Miller, 1991) and MHC class Isome of these Tg mice, a severe immunodeficiency with
loss of T cells and alterations of T cell activation was (Collins et al., 1998) proteins at the cell surface. This
effect of Nef is not species-specific, and downregulationobserved. However, none of these nef Tg mice devel-
oped a multi-organ syndrome and an immune disease of mouse CD4 in primary cells of CD3d/nef and CD2/
nef Tg mice has been documented (Brady et al., 1993;similar to the one observed in CD4C/HIVMutG Tg mice and
which most closely mimics human AIDS, as discussed Skowronski et al., 1993) and was confirmed here in the
CD4C/HIVMutG Tg mice. Although dramatic, the biologicalpreviously (Hanna et al., 1998). The different phenotypes
observed in the CD4C/HIVMutG Tg mice studied here are significance of CD4 downregulation is not clear, nor is
its role, if any, in the pathogenesis of this AIDS-likelikely to reflect the cell type(s) expressing the Tg, namely
the CD41 T cell subset and cells of the monocyte/macro- disease. Studies of Nef mutants unable to down-regu-
late CD4 (Iafrate et al., 1997) but competent in otherphage lineage. These are the same cells as those found
infected in HIV-1-positive individuals (Pantaleo and functions should help in elucidating the role of this phe-
nomenon in Nef-induced pathogenesis. Additionally, itFauci, 1995). The differences in the levels of Tg expres-
sion in CD4C/HIVMut Tg mice and in the other nef- is now well accepted that nef plays a positive role in
enhancing virus replication in vitro, particularly in pri-expressing Tg mice are unlikely to explain the different
phenotypes observed, since the same AIDS-like disease mary peripheral blood mononuclear cells and macro-
phages (Miller et al., 1994), and most importantly in vivo.developed, but after longer latent periods, in CD4C/
HIVMut Tg mice expressing the Tg at lower levels. In juvenile rhesus macaques and in the few patients
infected, respectively, with nef-deleted SIV or HIV-1 mu-The mechanism by which these various phenotypes
are induced in CD4C/HIVMut Tg mice is likely to be com- tant strains, viral loads remained low (Kestler et al., 1991;
Deacon et al., 1995; Kirchhoff et al., 1995). In addition,plex. We have explored TcR signaling events in Tg thy-
mus and found that Nef-expressing thymocytes were and most importantly, both humans and primates in-
fected with nef-deleted viruses failed to develop diseasein a state of activation and hyperresponsiveness with
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after a long period of observation, strongly suggesting are above (fast progression) or below (slow progression)
that nef is required for the pathogenecity of the virus a certain threshold. If a similar phenomenon governs
(Kestler et al., 1991; Deacon et al., 1995; Kirchhoff et the progression of human AIDS, the strong correlation
al., 1995). However, a role of nef independent of its role between the plasma viral load and progression to AIDS
in the virus replication could not be unmasked in these observed in humans (Ho, 1996) is likely to reflect the
experimental or clinical settings. Our results in Tg mice, intracellular Nef concentrations in specific target cells.
where virus replication is absent, clearly show that in- This possibly opens novel avenues for therapy.
deed nef can play an independent role in target cells,
apparently affecting them in such a way that a severe Experimental Procedures
AIDS-like disease is induced.
Transgene Construction and Generation of Tg MiceThe disease arising in the CD4C/HIVMutG Tg mice af-
The CD4C/HIVMut transgenes were constructed by mutating thefects many organs. The induction of such numerous
NL4±3 HIV-1 genome of the CD4C/HIVwt Tg (Hanna et al., 1998).pathological changes in several organs of Tg mice fol-
The CD4C/HIVMutA Tg was generated by the addition of a 14-merlowing the expression of a single known gene product
oligonucleotide containing three stop codons in each open reading
(Nef) suggests a common underlying mechanism for the frame (ORF) (59-CTAGTCTAGACTAG-39, ªstop oligoº) at the SphI
multi-organ lesions. Since the Tg expression is largely (nucleotide [nt] 1447) and NdeI (nt 5123) sites of HIV-1NL4±3 to produce
restricted to CD41 T cells and cells of the monocyte/ gag and vif mutant genes, respectively. This oligo contains a XbaI
site allowing the screening of mutated clones. The pol gene wasmacrophage lineage, factor(s) released from one or
mutated by deleting the 22 base pair (bp) HincII fragment (nt 2498±some of these cell populations are likely to be involved
2521) followed by addition of the ªstop oligoº at this site. DNAsin disease appearance in CD4C/HIVMutG Tg mice. In vari-
with vpr or vpu gene mutation (deletion of nt 5622±5737 and ntous Tg mouse target organs, the pathological lesions
6062±6180, respectively) were available through the NIH AIDS Re-
are strikingly similar to those found in human AIDS, agent Program as plasmids p210±19 and p210±13 (Gibbs et al.,
especially pediatric AIDS (Calvelli and Rubinstein, 1990), 1994). The tat mutation was produced by PCR site-directed muta-
as we previously discussed (Hanna et al., 1998). This is genesis using primer 297 (59-CCAGGGCTATAGTCTAG-39), con-
taining G to T mutation at nt 5854, creating a stop codon. The CD4C/the case for early death (Enger et al., 1996), wasting
HIVMutB transgene was generated by the addition of ªstop oligoº in(Coodley et al., 1994) and failure to thrive (Calvelli and
the env gene at the NdeI site (nt 6400). The CD4C/HIVMutC transgeneRubinstein, 1990), thymic atrophy, lymphadenopathy
was constructed from mutA by interrupting the nef ORF. This wasand preferential loss of CD41 T cells (Pantaleo and Fauci,
accomplished by filling the XhoI site (nt 8887) with Klenow. The
1995), tubulo-interstitial nephritis (Seney et al., 1990) CD4C/HIVMutG transgene was constructed from mutant A by inter-
and lymphoid interstitial pneumonitis (McSherry, 1996), rupting the rev and env genes by introducing the ªstop oligoº at the
which constituted the major lesions of the CD4C/HIVMut SacI (nt 6003) and NdeI (nt 6400) sites, respectively. The CD4C/
HIVMutH transgene was generated by ligating the 6.5 kbp BssHII-NheITg mice. Therefore, the remarkable similarities of these
HIV-1 fragment from the CD4C/HIVwt DNA with the 39-end 3.2kbpmulti-organ lesions in CD4C/HIVMut Tg mice and in hu-
NheI-AatII fragment of the mutant C DNA containing the nef muta-man AIDS strongly suggest that Nef has similar, if not
tion. All mutations were screened by XbaI digestion whenever possi-identical, effects in murine target cells, to its effects in
ble and confirmed by sequencing. All transgene DNAs were isolated
human target cells. This possibility is reenforced by the from the vector by AatII digestion and purified to produce Tg mice,
fact that the effectors, which are known to interact with as described before (Hanna et al., 1998).
Nef (Harris, 1996), appear to be well conserved in mouse
and man. If correct, this suggestion would imply that, Northern Analysis
Total RNAs were prepared from different tissues, and 10 mg wasas in CD4C/HIVMutG Tg mice, nef harbors an important
electrophoresed on formaldehyde agarose gels and processed fordeterminant of pathogenicity of HIV-1 in humans and
hybridization with the 32P-labeled 3.5 kbp SacI (39 end) or 1.4 kbpmay be responsible for the major pathological manifes-
HindIII-SacI (nef-specific) NL4±3 HIV-1 probe, as previously de-tations of human AIDS. The mouse model developed
scribed (Hanna et al., 1998).
here would be quite appropriate to assay the pathogenic
potential of different nef alleles arising in infected indi-
Detection of HIV-1 Proteins
viduals exhibiting distinct clinical courses. This novel Detection of HIV-1 proteins by Western immunoblotting was per-
function of nef, that is, its ability to induce an AIDS-like formed as previously described (Goudreau et al., 1996). Polyclonal
disease in Tg mice, may be most relevant to assay. The goat antibodies to gp160 (ERC-188) (1:5000) were obtained through
the NIH AIDS Reagent Program. Polyclonal rabbit antibodies againstconstitutive HIV-1 expression through the hCD4 regula-
Nef were obtained from V. Erfle (1:1000). Horse-radish peroxidase-tory sequences, although distinct from the LTR-driven
conjugated secondary antibodies (goat or rabbit) were used atviral expression, is likely to mimic a state of productive
1:6000 dilution. Proteins were detected using an enhanced chemilu-infection in human cells.
minescent substrate (Amersham). The amount of protein in lysates
Furthermore, the profound influence of the levels of was quantitated using a Micro BCA assay (Sigma). HIV-1 p24 gag
Nef expression on the latency of the AIDS-like disease proteins were quantified by using the Abbott HIVAG-1 Monoclonal
of CD4/HIVMut Tg mice suggests that this same parame- ELISA kit, as previously described (Goudreau et al., 1996).
ter may also be critical in human AIDS. We previously
noticed such a correlation while studying the CD4C/ Anti-Phosphotyrosine Immunoblotting
Thymocytes were stimulated with a-CD3 (145±2C11) (5 mg/ml)HIVwt Tg and chimeric mice (Hanna et al., 1998). The
(Skowronski et al., 1993) and RIPA extracts made as previouslycorrelation is better documented here with the CD4C/
described (Goudreau et al., 1996). Lysates were either untreated orHIVMut Tg mice. The outcome of disease seems to de-
immunoprecipitated with anti-LAT antibodies (Upstate Biotechnol-
pend entirely on the levels of the nef gene expression in ogy [UBI]) and Protein G-Agarose (Boehringer) before electrophore-
the target cells. Even more interesting, our data indicate sis on SDS-PAGE or directly run on gels and immunoblotted with
that disease progression follows two very distinct kinet- a-phosphotyrosine (4G10) (UBI) or a-phospho p44/42 MAP kinase
rabbit antibodies (New England Biolabs).ics depending on whether the intracellular levels of Nef
Cell
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Microscopic Analysis and ISH Hanna, Z., Simard, C., and Jolicoeur, P. (1994). Specific expression
of the human CD4 gene in mature CD41CD82 and immatureLymphoid and nonlymphoid organs were processed as previously
described (Hanna et al., 1998) for microscopic assessment. ISH was CD41CD81T cells, and in macrophage of transgenic mice. Mol. Cell.
Biol. 14, 1084±1094.performed on frozen or paraffin-embedded tissues or peritoneal
macrophages as described previously (Goudreau et al., 1996). Hanna, Z., Kay, D.G., Cool, M., Jothy, S., Rebai, N., and Jolicoeur,
P. (1998). Transgenic mice expressing human immunodeficiency
virus type 1 in immune cells develop a severe AIDS-like disease. J.FACS Analysis and Proliferation Assays
Virol. 72, 121±132.FACS analysis and cell proliferation assays were performed on
Harris, M. (1996). From negative factor to a critical role in viruslymphoid cells prepared from Tg and non-Tg aged-matched lit-
pathogenesis: the changing fortunes of Nef. J. Gen. Virol. 77, 2379±termates, as previously described (Huang et al., 1991; Hanna et al.,
2392.1998).
Herskowitz, A. (1996). Cardiomyopathy and other symptomatic heart
diseases associated with HIV infection. Curr. Opin. Cardiol. 11,Hematologic Parameters
325±331.Differential counts were performed on Wright's stained blood
Ho, D.D. (1996). Viral counts count in HIV infection. Science 272,smears taken from Tg and non-Tg control animals. Analysis was
1124±1125.also performed with the Instrument Technicon H.1 System (Bayer
Co.). ELISAs for detection of total serum Ig levels were performed, Huang, M., Simard, C., Kay, D.G., and Jolicoeur, P. (1991). The
as previously described (Hanna et al., 1998). majority of cells infected with the defective murine AIDS virus belong
to the B cell lineage. J. Virol. 65, 6562±6571.
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